Reed Elsevier NV AGM 24 April 2012

Regulatory News:

For immediate release
25 April 2012

Reed Elsevier NV announces that the Annual General Meeting of Shareholders (AGM), held in Amsterdam on 24 April, approved the 2011 financial statements and determined the final dividend for 2011 at € 0.326 per ordinary share of € 0.07 nominal value. After taking account of the interim dividend paid in August 2011 of € 0.110 per ordinary share the total dividend is € 0.436 per ordinary share.

All resolutions were approved by the AGM. These include: the appointment of David Brennan as member of the Supervisory Board with effect from 1 November 2012, the re-appointment of Erik Engstrom and Mark Armour as members of the Executive Board and the re-appointment of all members of the Supervisory Board.

The results of the voting on each resolution are set out below:

Resolution	Â	For	Â	%	Â	Against	Â	%	Â	Votes withheld
3. Adoption of the 2011 Annual Financial Statements		452,638,668		99.99%		33,482		0.01%		10,414
4a. Release from liability of members of the Executive Board		446,387,972		99.26%		3,316,063		0.74%		2,978,455
4b. Release from liability of members of the Supervisory Board		446,389,164		99.26%		3,315,056		0.74%		2,978,455
5. Determination and distribution of dividend		452,663,608		100.00%		4,214		0.00%		12,424
6. Appointment of external auditors		443,401,622		98.89%		4,963,600		1.11%		4,315,952
7a. Appointment David Brennan		450,621,840		99,95%		233,568		0.05%		1,827,269
7b. Re-appointment Mark Elliott		449,933,959		99.89%		512,068		0.11%		2,235,219
7c. Re-appointment Anthony Habgood		450,691,538		99.97%		116,296		0.03%		1,874,841
7d. Re-appointment Adrian Hennah		436,790,052		96.90%		13,966,704		3.10%		1,925,921
7e. Re-appointment Lisa Hook		436,888,997		96.89%		14,017,540		3.11%		1,776,105
7f. Re-appointment Marike van Lier Lels		436,180,822		96.73%		14,725,498		3.27%		1,776,337
7g. Re-appointment Robert Polet		436,017,529		96.72%		14,787,259		3.28%		1,876,341
7h. Re-appointment David Reid		432,571,373		96.59%		15,270,770		3.41%		4,840,531
7i. Re-appointment Ben van der Veer		450,810,780		99.98%		95,700		0.02%		1,776,195
8a. Re-appointment Erik Engstrom		450,716,362		99,96%		191,270		0.04%		1,774,953
8b. Re-appointment Mark Armour		437,826,473		97.19%		12,640,358		2.81%		2,214,813
9. Delegation to the Executive Board of the authority to acquire shares in the Company		447,992,205		99.37%		2,841,063		0.63%		1,849,399
10a. Designation of the Combined Board as authorised body to issue shares and to grant rights to acquire shares in the capital of the Company		425,368,759		94.44%		25,043,474		5.56%		2,269,007
10b. Extension of the designation of the Combined Board as authorised body to limit or exclude pre-emptive rights to the issuance of shares		397,491,692		87.83%		55,101,540		12.17%		89,293

Note:

Votes 'withheld' are not counted in the calculation of the proportion of votes 'for' or 'against' a resolution.

-ENDS-

Issued on behalf of Reed Elsevier NV

Contacts:

Reed Elsevier NV